Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling

While inflammation induced by Toll-like receptor (TLR) signaling is required to combat infection, persistent inflammation can damage host tissues and contribute to a myriad of acute and chronic inflammatory disorders. Thus, it is essential not only that TLR signaling be activated in the presence of...

Full description

Bibliographic Details
Main Authors: Frank Fang Yao Lee, Scott Alper
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1023567/full
_version_ 1798013987222192128
author Frank Fang Yao Lee
Frank Fang Yao Lee
Scott Alper
Scott Alper
author_facet Frank Fang Yao Lee
Frank Fang Yao Lee
Scott Alper
Scott Alper
author_sort Frank Fang Yao Lee
collection DOAJ
description While inflammation induced by Toll-like receptor (TLR) signaling is required to combat infection, persistent inflammation can damage host tissues and contribute to a myriad of acute and chronic inflammatory disorders. Thus, it is essential not only that TLR signaling be activated in the presence of pathogens but that TLR signaling is ultimately terminated. One mechanism that limits persistent TLR signaling is alternative pre-mRNA splicing. In addition to encoding the canonical mRNAs that produce proteins that promote inflammation, many genes in the TLR signaling pathway also encode alternative mRNAs that produce proteins that are dominant negative inhibitors of signaling. Many of these negative regulators are induced by immune challenge, so production of these alternative isoforms represents a negative feedback loop that limits persistent inflammation. While these alternative splicing events have been investigated on a gene by gene basis, there has been limited systemic analysis of this mechanism that terminates TLR signaling. Here we review what is known about the production of negatively acting alternative isoforms in the TLR signaling pathway including how these inhibitors function, how they are produced, and what role they may play in inflammatory disease.
first_indexed 2024-04-11T15:11:25Z
format Article
id doaj.art-21e6cd3025054385ad1e5ae3613c5c1a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T15:11:25Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-21e6cd3025054385ad1e5ae3613c5c1a2022-12-22T04:16:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-12-011310.3389/fimmu.2022.10235671023567Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signalingFrank Fang Yao Lee0Frank Fang Yao Lee1Scott Alper2Scott Alper3Department of Immunology and Genomic Medicine and Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, United StatesDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz, CO, United StatesDepartment of Immunology and Genomic Medicine and Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, United StatesDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz, CO, United StatesWhile inflammation induced by Toll-like receptor (TLR) signaling is required to combat infection, persistent inflammation can damage host tissues and contribute to a myriad of acute and chronic inflammatory disorders. Thus, it is essential not only that TLR signaling be activated in the presence of pathogens but that TLR signaling is ultimately terminated. One mechanism that limits persistent TLR signaling is alternative pre-mRNA splicing. In addition to encoding the canonical mRNAs that produce proteins that promote inflammation, many genes in the TLR signaling pathway also encode alternative mRNAs that produce proteins that are dominant negative inhibitors of signaling. Many of these negative regulators are induced by immune challenge, so production of these alternative isoforms represents a negative feedback loop that limits persistent inflammation. While these alternative splicing events have been investigated on a gene by gene basis, there has been limited systemic analysis of this mechanism that terminates TLR signaling. Here we review what is known about the production of negatively acting alternative isoforms in the TLR signaling pathway including how these inhibitors function, how they are produced, and what role they may play in inflammatory disease.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1023567/fullTLR signalinginnate immunityinflammationpre-mRNA splicingspliceosomeRNA binding protein
spellingShingle Frank Fang Yao Lee
Frank Fang Yao Lee
Scott Alper
Scott Alper
Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
Frontiers in Immunology
TLR signaling
innate immunity
inflammation
pre-mRNA splicing
spliceosome
RNA binding protein
title Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
title_full Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
title_fullStr Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
title_full_unstemmed Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
title_short Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling
title_sort alternative pre mrna splicing as a mechanism for terminating toll like receptor signaling
topic TLR signaling
innate immunity
inflammation
pre-mRNA splicing
spliceosome
RNA binding protein
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1023567/full
work_keys_str_mv AT frankfangyaolee alternativepremrnasplicingasamechanismforterminatingtolllikereceptorsignaling
AT frankfangyaolee alternativepremrnasplicingasamechanismforterminatingtolllikereceptorsignaling
AT scottalper alternativepremrnasplicingasamechanismforterminatingtolllikereceptorsignaling
AT scottalper alternativepremrnasplicingasamechanismforterminatingtolllikereceptorsignaling